LORTUSS DM is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Sallus Laboratories, Llc. The primary component is Dextromethorphan Hydrobromide; Doxylamine Succinate; Pseudoephedrine Hydrochloride.
| Product ID | 69036-120_41999ae8-18fc-49a0-a55c-ffa00f353ddd | 
| NDC | 69036-120 | 
| Product Type | Human Otc Drug | 
| Proprietary Name | LORTUSS DM | 
| Generic Name | Dextromethorphan Hydrobromide, Doxylamine Succinate, Pseudoephedrine Hydrochloride | 
| Dosage Form | Liquid | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2014-06-14 | 
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL | 
| Application Number | part341 | 
| Labeler Name | Sallus Laboratories, LLC | 
| Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PSEUDOEPHEDRINE HYDROCHLORIDE | 
| Active Ingredient Strength | 15 mg/5mL; mg/5mL; mg/5mL | 
| NDC Exclude Flag | E | 
| Listing Certified Through | 2017-12-31 | 
| Marketing Start Date | 2014-06-14 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | OTC MONOGRAPH FINAL | 
| Application Number | part341 | 
| Product Type | HUMAN OTC DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 2014-06-14 | 
| Marketing End Date | 2019-12-31 | 
| Inactivation Date | 2019-11-27 | 
| Reactivation Date | 2020-05-13 | 
| Ingredient | Strength | 
|---|---|
| DEXTROMETHORPHAN HYDROBROMIDE | 15 mg/5mL | 
| SPL SET ID: | 8afe55f6-7cb4-47c3-946d-6fa0126c23da | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  LORTUSS  88817798  not registered Live/Pending | Key Therapeutics, llc 2020-03-02 | 
|  LORTUSS  78149278  2818425 Dead/Cancelled | KOWA PHARMACEUTICALS AMERICA, INC. 2002-07-31 | 
|  LORTUSS  74276053  not registered Dead/Abandoned | WHITBY PHARMACEUTICALS, INC. 1992-05-18 |